Hard labour: bacterial infection of the skeleton

2000, Oral Health in America, A Report of the Surgeon General Irfan, 2001, Epidemiology of periodontal disease: a review and clinical perspectives, J. Int. Acad. Periodontol., 3, 14 Schierholz, 2001, Implant infections: a haven for opportunistic bacteria, J. Hosp. Infect., 49, 87, 10.1053/jhin.2001.1052 Ciampolini, 2000, Pathophysiology of chronic bacterial osteomyelitis. Why do antibiotics fail so often?, Postgrad. Med. J., 76, 479, 10.1136/pmj.76.898.479 Hunt, 2000, The molecular biology of Pasteurella multocida, Vet. Microbiol., 72, 3, 10.1016/S0378-1135(99)00183-2 Rodan, 1981, Role of osteoblasts in hormonal control of bone resorption – a hypothesis, Calcif. Tissue Int., 33, 349, 10.1007/BF02409454 Horowitz, 2001, Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands, Cytokine Growth Factor Rev., 12, 9, 10.1016/S1359-6101(00)00030-7 Emery, 1998, Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL, J. Biol. Chem., 273, 14363, 10.1074/jbc.273.23.14363 Hamilton, 2000, Ecological basis for dental caries, 219 Nair, 1996, Minireview – bacterially-induced bone destruction: mechanisms and misconceptions, Infect. Immun., 64, 2371, 10.1128/IAI.64.7.2371-2380.1996 Piec, 1999, Effect of MALP-2, a lipopeptide from Mycoplasma fermentans, on bone resorption in vitro, Infect. Immun., 67, 6281, 10.1128/IAI.67.12.6281-6285.1999 Reddi, 1995, Comparison of the osteolytic activity of surface-associated proteins of bacteria implicated in periodontal disease, Oral Dis., 1, 26, 10.1111/j.1601-0825.1995.tb00153.x Felix, 1992, Effect of Pasteurella multocida toxin on bone resorption in vitro, Infect. Immun., 60, 4984, 10.1128/IAI.60.12.4984-4988.1992 Henderson, 2003, Molecular pathogenicity of the oral opportunistic pathogen Actinobacillus actinomycetemcomitans, Annu. Rev. Microbiol., 57, 29, 10.1146/annurev.micro.57.030502.090908 Abu-Amer, 1997, Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its p55 receptor, J. Clin. Invest., 100, 1557, 10.1172/JCI119679 Jiang, 2002, Bacteria induce osteoclastogenesis via an osteoblast-independent pathway, Infect. Immun., 70, 3143, 10.1128/IAI.70.6.3143-3148.2002 Suda, 2002, Lipopolysaccharide supports survival and fusion of preosteoclasts independent of TNFα, IL-1 and RANKL, J. Cell. Physiol., 190, 101, 10.1002/jcp.10041 Kobayashi, 2001, Segregation of TRAF6-mediated signalling pathways clarifies its role in osteoclastogenesis, EMBO J., 20, 1271, 10.1093/emboj/20.6.1271 Kadono, 1999, Inhibition of osteoblastic cell differentiation by lipopolysaccharide extract from Porphyromonas gingivalis, Infect. Immun., 67, 2841, 10.1128/IAI.67.6.2841-2846.1999 Kikuchi, 2001, Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via toll-like receptors, J. Immunol., 166, 3574, 10.4049/jimmunol.166.5.3574 Kikuchi, 2003, Cot/Tpl2 is essential for RANKL induction by lipid A in osteoblasts, J. Dent. Res., 82, 546, 10.1177/154405910308200712 Sakuma, 2000, Impaired bone resorption by lipopolysaccharide in vivo in mice deficient in the prostaglandin E receptor EP4 subtype, Infect. Immun., 68, 6819, 10.1128/IAI.68.12.6819-6825.2000 Yoshimura, 2002, Lipopolysaccharides from periodontopathic bacteria Porphyromonas gingivalis and Capnocytophaga ochracea are antagonists for human toll-like receptor 4, Infect. Immun., 70, 218, 10.1128/IAI.70.1.218-225.2002 Lax, 2001, Pasteurella multocida toxin: the mitogenic toxin that stimulates signalling cascades to regulate growth and differentiation, Int. J. Med. Microbiol., 291, 261, 10.1078/1438-4221-00129 Mullan, 1996, Pasteurella multocida toxin is a mitogen for bone cells in primary culture, Infect. Immun., 64, 959, 10.1128/IAI.64.3.959-965.1996 Mullan, 1998, Pasteurella multocida toxin stimulates bone resorption by osteoclasts via interaction with osteoblasts, Calcif. Tissue Int., 63, 340, 10.1007/s002239900537 Kirby, 1995, The potent bone resorbing mediator of Actinobacillus actinomycetemcomitans is homologous to the molecular chaperone GroEL, J. Clin. Invest., 96, 1185, 10.1172/JCI118150 Meghji, 1997, Bacterial porins stimulate bone resorption, Infect. Immun., 65, 1313, 10.1128/IAI.65.4.1313-1316.1997 Kawata, 1997, Porphyromonas gingivalis fimbriae-stimulated bone resorption is inhibited through binding of the fimbriae to fibronectin, Infect. Immun., 65, 815, 10.1128/IAI.65.2.815-817.1997 Nair, 2000, Review: advances in our understanding of the bone and joint pathology caused by Staphylococcus aureus infection, Rheumatology (Oxf), 39, 821, 10.1093/rheumatology/39.8.821 Lengeling, 2001, The battle of two genomes: genetics of bacterial host/pathogen interactions in mice, Mamm. Genome, 12, 261, 10.1007/s003350040001 Slots, 1999, Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in human periodontal disease: occurrence and treatment, Periodontol. 2000, 20, 82, 10.1111/j.1600-0757.1999.tb00159.x Baker, 2000, Genetic control of susceptibility to Porphyromonas gingivalis-induced alveolar bone loss in mice, Infect. Immun., 68, 5864, 10.1128/IAI.68.10.5864-5868.2000 Baker, 2000, Adhesion molecule deficiencies increase Porphyromonas gingivalis-induced alveolar bone loss in mice, Infect. Immun., 68, 3103, 10.1128/IAI.68.6.3103-3107.2000 Graves, 2001, Tumor necrosis factor modulates fibroblast apoptosis, PMN recruitment, and osteoclast formation in response to P. gingivalis infection, J. Dent. Res., 80, 1875, 10.1177/00220345010800100301 Mackay, 2002, TNF ligands and receptors in autoimmunity: an update, Curr. Opin. Immunol., 14, 783, 10.1016/S0952-7915(02)00407-7 Hara, 1998, Histopathological study of the role of CD4- and CD8-positive T cells on bone resorption induced by Escherichia coli endotoxin, Calcif. Tissue Int., 63, 63, 10.1007/s002239900490 Baker, 1999, CD4 T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice, Infect. Immun., 67, 2804, 10.1128/IAI.67.6.2804-2809.1999 Baker, 2002, T cell knockout mice have diminished alveolar bone loss after oral infection with Porphyromonas gingivalis, FEMS Immunol. Med. Microbiol., 34, 45, 10.1111/j.1574-695X.2002.tb00601.x Teng, 2000, Functional human T cell immunity and osteoprotegerin-ligand control alveolar bone destruction in periodontal infection, J. Clin. Invest., 106, R59, 10.1172/JCI10763 Kazor, 2003, Diversity of bacterial populations on the tongue dorsa of patients with halitosis and healthy patients, J. Clin. Microbiol., 41, 558, 10.1128/JCM.41.2.558-563.2003 Chen, 1999, Interleukin-1 and tumour necrosis factor receptor signalling is not required for bacteria-induced osteoclastogenesis and bone loss but is essential for protecting the host from a mixed anaerobic infection, Am. J. Pathol., 155, 2145, 10.1016/S0002-9440(10)65532-0 Balto, 2001, Interleukin-6 deficiency increases inflammatory bone destruction, Infect. Immun., 69, 744, 10.1128/IAI.69.2.744-750.2001 Chae, 2002, Mice lacking monocyte chemoattractant protein 1 have enhanced susceptibility to an interstitial polymicrobial infection due to impaired monocyte recruitment, Infect. Immun., 70, 3164, 10.1128/IAI.70.6.3164-3169.2002 Graves, 2002, Developmentally regulated monocyte recruitment and bone resorption are modulated by functional deletion of the monocytic chemoattractant protein-1 gene, Bone, 31, 282, 10.1016/S8756-3282(02)00829-3 Sasaki, 2000, IL-10, but not IL-4, suppresses infection-stimulated bone resorption in vivo, J. Immunol., 165, 3626, 10.4049/jimmunol.165.7.3626 Kawashima, 1999, Infection-stimulated infraosseus inflammation and bone destruction is increased in P-/E-selectin knockout mice, Immunology, 97, 117, 10.1046/j.1365-2567.1999.00754.x Hou, 2000, Toll-like receptor 4-deficient mice have reduced bone destruction following mixed anaerobic infection, Infect. Immun., 68, 4681, 10.1128/IAI.68.8.4681-4687.2000 Tarkowski, 2001, Model systems: modeling human staphylococcal arthritis and sepsis in the mouse, Trends Microbiol., 9, 321, 10.1016/S0966-842X(01)02078-9 Tarkowski, 2002, Current status of pathogenetic mechanisms in staphylococcal arthritis, FEMS Microbiol. Lett., 217, 125, 10.1111/j.1574-6968.2002.tb11466.x Hultgren, 1998, TNF/Lymphotoxin-α double-mutant mice resist septic arthritis but display increased mortality in response to Staphylococcus aureus, J. Immunol., 161, 5937, 10.4049/jimmunol.161.11.5937 Hudson, 1995, Internalization of Staphylococcus aureus by cultured osteoblasts, Microb. Pathog., 19, 409, 10.1006/mpat.1995.0075 Alexander, 2001, Staphylococcus aureus and Salmonella enterica serovar Dublin induce tumour necrosis factor-related apoptosis-inducing ligand expression by normal mouse and human osteoblasts, Infect. Immun., 69, 1581, 10.1128/IAI.69.3.1581-1586.2001 Hotokezaka, 1998, Internalisation of Mycobacterium bovis Bacillus Calmette-Guérin into osteoblast-like MC3T3-E1 cells and bone resorptive responses of the cells against the infection, Scand. J. Immunol., 47, 453, 10.1046/j.1365-3083.1998.00318.x Ahmed, 2001, Staphylococcus aureus fibronectin binding proteins are essential for internalization by osteoblasts but do not account for differences in intracellular levels of bacteria, Infect. Immun., 69, 1581, 10.1128/IAI.69.5.2872-2877.2001 Alexander, 2003, Staphylococcus aureus-induced tumor necrosis factor – related apoptosis – inducing ligand expression mediates apoptosis and caspase-8 activation in infected osteoblasts, BMC Microbiol., 3, 5, 10.1186/1471-2180-3-5 Bost, 1999, Staphylococcus aureus infection of mouse or human osteoblasts induces high levels of interleukin-6 and interleukin-12 production, J. Infect. Dis., 180, 1912, 10.1086/315138 Louie, 2003, Biological response modifiers in the management of rheumatoid arthritis, Am. J. Health Syst. Pharm., 60, 346, 10.1093/ajhp/60.4.346 Oates, 2002, Clinical, radiographic and biochemical assessment of IL-1/TNFα antagonist inhibition of bone loss in experimental periodontitis, J. Clin. Periodontol., 29, 137, 10.1034/j.1600-051x.2002.290208.x Liu, 2003, Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction, Int. J. Mol. Med., 11, 17 Childs, 2002, In vivo RANK signaling blockade using the receptor activator of NF-kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis, J. Bone Miner. Res., 17, 192, 10.1359/jbmr.2002.17.2.192 Zou, 2003, CpG oligodeoxynucleotides modulate the osteoclastogenic activity of osteoblasts via toll-like receptor 9, J. Biol. Chem., 278, 16732, 10.1074/jbc.M212473200